ProfileGDS4718 / 225802_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 69% 72% 72% 73% 92% 94% 75% 73% 71% 76% 58% 89% 94% 92% 76% 79% 93% 89% 75% 75% 75% 76% 76% 75% 95% 75% 95% 71% 92% 81% 91% 56% 67% 93% 85% 90% 76% 73% 69% 72% 90% 78% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0302672
GSM549102patient 115, normal, homogenized [OPG study]6.7891269
GSM549104patient 119, normal, homogenized [OPG study]7.0641172
GSM549108patient 138, normal, homogenized [OPG study]6.9741572
GSM549119patient 077, normal, homogenized [OPG study]7.0757173
GSM549133patient 032, cancer, homogenized [OPG study]9.7203592
GSM549139patient 042, cancer, homogenized [OPG study]9.8818894
GSM549099patient 107, normal, homogenized [OPG study]7.2151475
GSM549109patient 139, normal, homogenized [OPG study]7.1125673
GSM549110patient 046, normal, homogenized [OPG study]6.9459271
GSM549114patient 063, normal, homogenized [OPG study]7.4374676
GSM549122patient 082, normal, homogenized [OPG study]6.0349458
GSM549134patient 033, cancer, homogenized [OPG study]8.9933789
GSM549136patient 036, cancer, homogenized [OPG study]10.019794
GSM549140patient 044, cancer, homogenized [OPG study]9.5972892
GSM549111patient 047, normal, homogenized [OPG study]7.498376
GSM549113patient 057, normal, homogenized [OPG study]7.7677979
GSM549132patient 031, cancer, homogenized [OPG study]9.6896693
GSM549137patient 038, cancer, homogenized [OPG study]9.0686889
GSM549142patient 047, cancer, homogenized [OPG study]7.2346775
GSM549100patient 110, normal, homogenized [OPG study]7.2803275
GSM549107patient 135, normal, homogenized [OPG study]7.3498875
GSM549115patient 068, normal, homogenized [OPG study]7.5338476
GSM549116patient 072, normal, homogenized [OPG study]7.5052676
GSM549120patient 078, normal, homogenized [OPG study]7.2983575
GSM549131patient 030, cancer, homogenized [OPG study]10.169795
GSM549118patient 074, normal, homogenized [OPG study]7.3622675
GSM549129patient 027, cancer, homogenized [OPG study]9.928595
GSM549123patient 088, normal, homogenized [OPG study]6.9832171
GSM549124patient 006, cancer, homogenized [OPG study]9.4073692
GSM549126patient 015, cancer, homogenized [OPG study]8.0162181
GSM549128patient 025, cancer, homogenized [OPG study]9.369891
GSM549103patient 117, normal, homogenized [OPG study]5.8962356
GSM549117patient 073, normal, homogenized [OPG study]6.5468367
GSM549138patient 041, cancer, homogenized [OPG study]9.8080593
GSM549141patient 045, cancer, homogenized [OPG study]8.5551785
GSM549130patient 028, cancer, homogenized [OPG study]9.1217190
GSM549101patient 111, normal, homogenized [OPG study]7.4121376
GSM549105patient 128, normal, homogenized [OPG study]7.0964473
GSM549106patient 134, normal, homogenized [OPG study]6.8432369
GSM549112patient 048, normal, homogenized [OPG study]7.0418872
GSM549125patient 011, cancer, homogenized [OPG study]9.1748490
GSM549127patient 024, cancer, homogenized [OPG study]7.7360978
GSM549135patient 035, cancer, homogenized [OPG study]9.6278992